Elevance Capital Stock vs Deferred Long Term Liab Analysis

ELV Stock

USD 402.55 1.05 0.26%

Elevance Health financial indicator trend analysis is much more than just examining Elevance Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elevance Health is a good investment. Please check the relationship between Elevance Health Capital Stock and its Deferred Long Term Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevance Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Capital Stock vs Deferred Long Term Liab

Capital Stock vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elevance Health Capital Stock account and Deferred Long Term Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Elevance Health's Capital Stock and Deferred Long Term Liab is -0.12. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Elevance Health, assuming nothing else is changed. The correlation between historical values of Elevance Health's Capital Stock and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Elevance Health are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Capital Stock i.e., Elevance Health's Capital Stock and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.12

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Elevance Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elevance Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevance Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.At this time, Elevance Health's Discontinued Operations is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.21 in 2024, whereas Tax Provision is likely to drop slightly above 1.7 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	36.0B	40.0B	47.0B	56.0B
Total Revenue	138.6B	156.6B	171.3B	179.9B

Gross Profit Total Revenue

Elevance Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Net Debt	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Other Liab	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Short Term Investments	Other Current Assets	Intangible Assets	Property Plant Equipment	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity
Total Assets		0.97	0.99	0.93	-0.24	-0.12	0.98	0.47	0.84	0.16	0.65	0.74	0.81	0.58	0.9	0.98	0.98	0.81	0.9	0.76	0.81	0.82	-0.14	0.33	0.78	0.09
Short Long Term Debt Total	0.97		0.96	0.98	-0.37	-0.16	0.99	0.43	0.79	0.04	0.57	0.72	0.76	0.56	0.86	1.0	0.92	0.77	0.89	0.69	0.74	0.84	-0.11	0.44	0.85	0.12
Total Stockholder Equity	0.99	0.96		0.92	-0.27	-0.01	0.96	0.58	0.84	0.09	0.6	0.78	0.8	0.59	0.87	0.96	0.97	0.81	0.94	0.74	0.79	0.87	-0.07	0.35	0.78	0.23
Net Debt	0.93	0.98	0.92		-0.48	-0.08	0.96	0.48	0.73	-0.07	0.48	0.74	0.68	0.56	0.74	0.97	0.87	0.72	0.89	0.6	0.65	0.87	-0.11	0.51	0.84	0.18
Other Assets	-0.24	-0.37	-0.27	-0.48		-0.08	-0.34	-0.24	-0.03	0.8	0.32	-0.54	0.05	-0.22	-0.03	-0.37	-0.18	-0.08	-0.37	0.13	0.06	-0.63	-0.26	-0.96	-0.31	-0.4
Common Stock Shares Outstanding	-0.12	-0.16	-0.01	-0.08	-0.08		-0.1	0.7	-0.18	-0.24	-0.37	0.19	-0.29	-0.25	-0.33	-0.18	-0.03	-0.14	0.24	-0.34	-0.34	0.17	0.22	-0.07	-0.17	0.77
Non Current Liabilities Total	0.98	0.99	0.96	0.96	-0.34	-0.1		0.48	0.81	0.11	0.6	0.74	0.76	0.55	0.85	0.99	0.94	0.77	0.91	0.69	0.74	0.82	-0.18	0.38	0.81	0.12
Other Stockholder Equity	0.47	0.43	0.58	0.48	-0.24	0.7	0.48		0.52	-0.07	0.25	0.69	0.41	0.36	0.24	0.43	0.49	0.51	0.78	0.35	0.36	0.68	0.07	0.16	0.38	0.79
Total Liab	0.84	0.79	0.84	0.73	-0.03	-0.18	0.81	0.52		0.38	0.9	0.68	0.98	0.8	0.8	0.82	0.81	0.96	0.81	0.96	0.97	0.69	-0.3	0.11	0.66	0.04
Other Current Liab	0.16	0.04	0.09	-0.07	0.8	-0.24	0.11	-0.07	0.38		0.71	-0.26	0.42	0.03	0.33	0.07	0.17	0.29	0.01	0.49	0.44	-0.33	-0.46	-0.78	0.01	-0.45
Total Current Liabilities	0.65	0.57	0.6	0.48	0.32	-0.37	0.6	0.25	0.9	0.71		0.34	0.92	0.68	0.71	0.61	0.62	0.83	0.52	0.94	0.91	0.31	-0.43	-0.24	0.48	-0.26
Other Liab	0.74	0.72	0.78	0.74	-0.54	0.19	0.74	0.69	0.68	-0.26	0.34		0.6	0.63	0.51	0.73	0.74	0.68	0.85	0.53	0.57	0.91	-0.09	0.56	0.62	0.44
Retained Earnings	0.81	0.76	0.8	0.68	0.05	-0.29	0.76	0.41	0.98	0.42	0.92	0.6		0.79	0.83	0.78	0.77	0.93	0.73	0.99	0.99	0.62	-0.28	0.07	0.65	-0.03
Accounts Payable	0.58	0.56	0.59	0.56	-0.22	-0.25	0.55	0.36	0.8	0.03	0.68	0.63	0.79		0.48	0.6	0.56	0.8	0.57	0.79	0.76	0.6	-0.19	0.28	0.5	0.04
Cash	0.9	0.86	0.87	0.74	-0.03	-0.33	0.85	0.24	0.8	0.33	0.71	0.51	0.83	0.48		0.87	0.86	0.78	0.71	0.78	0.83	0.61	-0.11	0.18	0.71	-0.06
Long Term Debt	0.98	1.0	0.96	0.97	-0.37	-0.18	0.99	0.43	0.82	0.07	0.61	0.73	0.78	0.6	0.87		0.93	0.79	0.89	0.72	0.77	0.84	-0.16	0.44	0.82	0.1
Short Term Investments	0.98	0.92	0.97	0.87	-0.18	-0.03	0.94	0.49	0.81	0.17	0.62	0.74	0.77	0.56	0.86	0.93		0.77	0.89	0.73	0.77	0.79	-0.14	0.26	0.68	0.08
Other Current Assets	0.81	0.77	0.81	0.72	-0.08	-0.14	0.77	0.51	0.96	0.29	0.83	0.68	0.93	0.8	0.78	0.79	0.77		0.78	0.88	0.89	0.7	-0.17	0.16	0.69	0.09
Intangible Assets	0.9	0.89	0.94	0.89	-0.37	0.24	0.91	0.78	0.81	0.01	0.52	0.85	0.73	0.57	0.71	0.89	0.89	0.78		0.65	0.7	0.92	-0.08	0.38	0.71	0.43
Property Plant Equipment	0.76	0.69	0.74	0.6	0.13	-0.34	0.69	0.35	0.96	0.49	0.94	0.53	0.99	0.79	0.78	0.72	0.73	0.88	0.65		0.99	0.53	-0.32	-0.01	0.56	-0.12
Property Plant And Equipment Net	0.81	0.74	0.79	0.65	0.06	-0.34	0.74	0.36	0.97	0.44	0.91	0.57	0.99	0.76	0.83	0.77	0.77	0.89	0.7	0.99		0.6	-0.29	0.08	0.6	-0.08
Non Current Assets Total	0.82	0.84	0.87	0.87	-0.63	0.17	0.82	0.68	0.69	-0.33	0.31	0.91	0.62	0.6	0.61	0.84	0.79	0.7	0.92	0.53	0.6		0.08	0.68	0.68	0.48
Non Currrent Assets Other	-0.14	-0.11	-0.07	-0.11	-0.26	0.22	-0.18	0.07	-0.3	-0.46	-0.43	-0.09	-0.28	-0.19	-0.11	-0.16	-0.14	-0.17	-0.08	-0.32	-0.29	0.08		0.32	-0.14	0.26
Cash And Short Term Investments	0.33	0.44	0.35	0.51	-0.96	-0.07	0.38	0.16	0.11	-0.78	-0.24	0.56	0.07	0.28	0.18	0.44	0.26	0.16	0.38	-0.01	0.08	0.68	0.32		0.34	0.31
Net Receivables	0.78	0.85	0.78	0.84	-0.31	-0.17	0.81	0.38	0.66	0.01	0.48	0.62	0.65	0.5	0.71	0.82	0.68	0.69	0.71	0.56	0.6	0.68	-0.14	0.34		0.18
Common Stock Total Equity	0.09	0.12	0.23	0.18	-0.4	0.77	0.12	0.79	0.04	-0.45	-0.26	0.44	-0.03	0.04	-0.06	0.1	0.08	0.09	0.43	-0.12	-0.08	0.48	0.26	0.31	0.18

Click cells to compare fundamentals

Elevance Health Account Relationship Matchups

Elevance Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	77.5B	86.6B	97.3B	102.8B	108.9B	57.8B
Short Long Term Debt Total	20.1B	20.0B	23.0B	24.1B	25.1B	12.6B
Total Stockholder Equity	31.7B	33.2B	36.1B	36.3B	39.3B	23.6B
Net Debt	15.1B	14.3B	18.2B	16.7B	18.6B	9.6B
Other Assets	(11.3B)	(13.7B)	(14.8B)	1.9B	1.7B	1.8B
Liabilities And Stockholders Equity	77.5B	86.6B	97.3B	102.8B	108.9B	57.8B
Non Current Liabilities Total	20.0B	21.4B	23.8B	26.7B	27.7B	14.1B
Other Stockholder Equity	9.4B	9.2B	9.1B	9.1B	8.9B	11.1B
Total Liab	45.7B	53.4B	61.2B	66.4B	69.5B	73.0B
Other Current Liab	(16.4B)	(18.8B)	(21.5B)	31.0B	15.5B	16.3B
Total Current Liabilities	16.4B	18.8B	21.5B	39.7B	41.8B	43.9B
Other Liab	3.8B	4.6B	5.1B	3.6B	4.1B	3.9B
Retained Earnings	22.6B	23.8B	27.1B	29.7B	31.7B	33.3B
Accounts Payable	13.0B	16.9B	18.5B	5.6B	23.0B	24.2B
Cash	4.9B	5.7B	4.9B	7.4B	6.5B	3.3B
Long Term Debt	17.8B	19.3B	21.2B	22.3B	23.2B	12.5B
Short Term Investments	19.7B	23.4B	26.3B	26.0B	29.6B	15.6B
Other Current Assets	29.1B	34.3B	38.5B	39.3B	43.5B	45.7B
Intangible Assets	8.7B	9.4B	10.6B	10.3B	10.3B	8.3B
Property Plant Equipment	3.1B	3.5B	3.9B	4.3B	5.0B	5.2B
Property Plant And Equipment Net	3.1B	3.5B	3.9B	4.3B	4.4B	4.6B
Non Current Assets Total	53.5B	60.1B	67.5B	47.2B	48.9B	43.7B
Non Currrent Assets Other	(801M)	(1.7B)	(103M)	(19.8B)	(21.8B)	(20.7B)
Cash And Short Term Investments	24.6B	29.2B	31.1B	7.4B	6.5B	6.2B
Net Receivables	10.6B	5.7B	7.8B	9.0B	10.0B	6.2B
Property Plant And Equipment Gross	2.2B	2.7B	3.1B	3.5B	4.0B	4.2B
Total Current Assets	35.2B	40.1B	44.6B	55.6B	60.0B	63.0B
Accumulated Other Comprehensive Income	(296M)	150M	(178M)	(2.5B)	(1.3B)	(1.2B)
Short Term Debt	2.0B	2.3B	700M	1.9B	1.9B	1.2B
Current Deferred Revenue	1.0B	1.3B	1.2B	1.1B	1.4B	1.5B
Good Will	20.5B	21.7B	24.2B	24.4B	25.3B	17.6B
Inventory	(29.1B)	(34.3B)	(38.5B)	(11.4B)	(46.3B)	(44.0B)
Retained Earnings Total Equity	22.6B	23.8B	27.1B	29.7B	34.2B	17.6B
Deferred Long Term Liab	2.2B	2.0B	2.8B	2.0B	2.3B	2.4B
Net Tangible Assets	2.6B	2.1B	1.2B	1.6B	1.9B	1.9B
Long Term Debt Total	17.8B	19.3B	21.2B	22.3B	25.7B	17.9B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC